Biotech industry pe ratio
Web2 days ago · P/E Ratio Insights for Gilead Sciences. In the current session, the stock is trading at $82.91, after a 0.38% increase. Over the past month, Gilead Sciences Inc. stock increased by 3.94%, and in ... WebThe price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to …
Biotech industry pe ratio
Did you know?
WebDec 21, 2007 · Identical earnings growth rates of 10 percent are expected for each industry, with a price/earnings ratio of 16.7 for biotech and 14.1 for pharma. Baseline does not break out industry-wide stock ... WebApr 11, 2024 · Investors are optimistic on the American Life Sciences industry, and appear confident in long term growth rates. The industry is trading at a PE ratio of 66.7x which is higher than its 3-year average PE of 45.0x. The 3-year average PS ratio of 5.7x is higher than the industry's current PS ratio of 4.7x. Past Earnings Growth.
WebApr 6, 2024 · The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether … WebPE Ratio by Sector (US) Data Used: Multiple data services. Date of Analysis: ... Industry Name: Number of firms % of Money Losing firms (Trailing) Current PE: Trailing PE ... (Biotechnology) 598: 92.81%: 81.44: 113.80: 34.86: 152.24: 17.15-4.84%: NA: Drugs … As an example, the PE ratio for the sector is not a simple average of the PE ratios of …
WebApr 6, 2024 · FA Report PDF. XBI is one of a handful of biotech ETFs available, offering exposure to a corner of the market that can perform well during periods of consolidation and is capable of big jumps in the event of major drug approvals. XBI focuses on a narrow sector of the health care sector, and as such is probably too precise for most investors ... WebNov 21, 2012 · A P/E of 10 tells you that you're paying $10 for $1 of past earnings. In the health care industry, Pfizer ( PFE 0.34%) records a P/E of 19. That's less than Johnson & Johnson 's ( JNJ -0.09%) P/E ...
WebCurrent and historical p/e ratio for Pfizer (PFE) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent …
WebApr 11, 2024 · Price/Earnings Ratio FY1 19.12: Index Statistics as of Apr 12 2024. Average Size Size Range Weighted Average Market Cap Mean Median ... The S&P Biotech Select Industry Index is an equal-weighted index that draws constituents from the Biotechnology segment of the S&P TMI. biotech minneapolis mnWebFor the Medical Instruments & Supplies subindustry, Sartorius Stedim Biotech's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below: * Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the … biotech middle eastWebApr 11, 2024 · The industry is trading at a PE ratio of 25.4x which is higher than its 3-year average PE of 22.6x. The industry is trading close to its 3-year average PS ratio of 0.71x. Past Earnings Growth. The earnings for companies in the Healthcare industry have grown 6.3% per year over the last three years. biotech minor tuftsWebOct 31, 2024 · For instance, its P/E ratio is 10.9, below the industry median of 28.8. Also, Innoviva’s Shiller P/E ratio is 16.3 times, lower than 80% of biotech competitors. Notably, though, the company ... daisy\\u0027s ice cream corningWebDetailed research and segmentation for the main products and markets. An assessment of the competitive landscape and market shares for major companies. And of course, much more. IBISWorld reports on thousands of industries around the world. Our clients rely on our information and data to stay up-to-date on industry trends across all industries. daisy\u0027s ice cream corningWebMarket Cap. JP¥98.22b. 4569 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA. Key Statistics. Enterprise Value/Revenue. 0.9x. Enterprise Value/EBITDA. 9.5x. daisy\\u0027s in the park radlettWeb26 rows · See a list of Biotechnology using the Yahoo Finance screener. Create your … daisy\u0027s in the sky